Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CALCIPOTRIENE Cause Therapeutic product effect incomplete? 123 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 123 reports of Therapeutic product effect incomplete have been filed in association with CALCIPOTRIENE (SORILUX). This represents 9.2% of all adverse event reports for CALCIPOTRIENE.

123
Reports of Therapeutic product effect incomplete with CALCIPOTRIENE
9.2%
of all CALCIPOTRIENE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Therapeutic product effect incomplete From CALCIPOTRIENE?

Of the 123 reports, 1 (0.8%) required hospitalization.

Is Therapeutic product effect incomplete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CALCIPOTRIENE. However, 123 reports have been filed with the FAERS database.

What Other Side Effects Does CALCIPOTRIENE Cause?

Drug ineffective (663) Psoriasis (342) Product use in unapproved indication (147) Pruritus (108) Treatment failure (102) Skin exfoliation (97) Arthralgia (81) Erythema (79) Rash (75) Off label use (73)

What Other Drugs Cause Therapeutic product effect incomplete?

ALBUTEROL (8,496) ADALIMUMAB (6,986) PREDNISONE (6,709) METHOTREXATE (6,037) TOFACITINIB (4,914) SECUKINUMAB (4,661) BUDESONIDE\FORMOTEROL (4,392) TIOTROPIUM (4,327) MEPOLIZUMAB (4,106) ETANERCEPT (3,961)

Which CALCIPOTRIENE Alternatives Have Lower Therapeutic product effect incomplete Risk?

CALCIPOTRIENE vs CALCITONIN CALCIPOTRIENE vs CALCITONIN SALMON CALCIPOTRIENE vs CALCITRIOL CALCIPOTRIENE vs CALCITRIOL\CALCIUM\ZINC CALCIPOTRIENE vs CALCIUM

Related Pages

CALCIPOTRIENE Full Profile All Therapeutic product effect incomplete Reports All Drugs Causing Therapeutic product effect incomplete CALCIPOTRIENE Demographics